After skin cancer, prostate cancer is the most common cancer among men.
And the incidence of advanced prostate cancer cases is on the rise, according
to recent studies.
Fortunately, due to early detection and effective treatment options, prostate
cancer is more survivable than ever. In fact, when detected in an early
stage, the five-year survival rate for those diagnosed with prostate cancer
is almost 100 percent. This is why preventative screening is so important.
Talk to your doctor about screenings used to detect prostate cancer.
Click here for a referral to an RWJBarnabas Health urologist or primary care physician.
Prostate Cancer: Stats and Facts
- The American Cancer Society reports that prostate cancer is more common
in African-American men and in Caribbean men of African ancestry than
in men of other races. African-American men are more than twice as likely
to die of prostate cancer as Caucasian men. The disease occurs less often
in Asian-American and Hispanic Latino men than in non-Hispanic Caucasian men.
- Prostate cancer is a malignant tumor that usually starts in the outer part
of the prostate and typically grows very slowly. Many men with the disease
will never know they have the condition.
- Prostate cancer is characterized by “grade” and “stage”
– the size and extent of the tumor. Early stage prostate cancer
– Stage T1 and T2 – are limited to the prostate gland.
- Stage T3 has advanced to tissue immediately outside the gland and Stage
T4 has spread to other parts of the body.
- When detected in an early stage, the five-year survival rate for those
diagnosed with prostate cancer is almost 100 percent.
- Prostate cancer screening can help find cancer before an individual has
symptoms, and in its earliest stage, when treatment is most effective.
- One man in seven will be diagnosed with prostate cancer during his lifetime.
- Prostate cancer develops mainly in older men. The average age at the time
of diagnosis is about 66.
- Prostate cancer is the second leading cause of cancer death in American
men, behind only skin cancer.
- About one man in 39 will die from prostate cancer.
Talk to your doctor about two screenings used to detect prostate cancer:
the prostate specific antigen (PSA) blood test and a digital rectal examination (DRE).
Click here to locate to an RWJBarnabas Health urologist or primary care physician.
RWJBarnabas Health: Leading the Way in Prostate Cancer Treatment
The cancer centers of RWJBarnabas Health utilize the latest technology
and therapies to prevent, diagnose and treat prostate cancer. Our multidisciplinary
team of specialists works in collaboration to develop a highly effective
and personalized treatment plan that best suits the patient’s needs
and gets him back on the road to recovery. Treatment of prostate cancer
depends on several factors, including the age and health of the patient,
the stage of the cancer and the aggressiveness of the cells.
- The Cancer Center at Clara Maass Medical Center, Belleville
- The Cancer Center at Saint Barnabas Medical Center, Livingston
- The Cancer Hospital of New Jersey at Robert Wood Johnson University Hospital
New Brunswick, New Brunswick
- The Frederick B. Cohen, MD, Comprehensive Cancer and Blood Disorders Center
at Newark Beth Israel Medical Center, Newark
- Oncology Services at Jersey City Medical Center, Jersey City
- J. Phillip Citta Regional Cancer Center at Community Medical Center, Toms River
- Leon Hess Cancer Center at Monmouth Medical Center, Long Branch
- The Steeplechase Cancer Center at Robert Wood Johnson University Hospital